Further analysis showed that the constructed seven-gene signature was significantly overexpressed in ER+/HER2+ subtypes and correlated with advanced tumor stage, suggesting that it may be used as a potential prognostic marker for hormone receptor-positive breast cancer. Here, ERBB2 is linked to neoplasm.